Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial

IMPORTANCE: Evidence of effective smoking cessation interventions in patients with diabetes is limited. The unique behavioral and metabolic characteristics of smokers with type 2 diabetes warrants a randomized clinical trial of the smoking cessation drug varenicline. OBJECTIVE: To evaluate the effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Cristina, Walicka, Magdalena, Caponnetto, Pasquale, Cibella, Fabio, Maglia, Marilena, Alamo, Angela, Campagna, Davide, Frittitta, Lucia, Di Mauro, Maurizio, Caci, Grazia, Krysinski, Arkadiusz, Franek, Edward, Polosa, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214580/
https://www.ncbi.nlm.nih.gov/pubmed/35727580
http://dx.doi.org/10.1001/jamanetworkopen.2022.17709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214580/
https://www.ncbi.nlm.nih.gov/pubmed/35727580
http://dx.doi.org/10.1001/jamanetworkopen.2022.17709

Ejemplares similares